Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 7, 2008; 14(9): 1394-1398
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1394
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1394
Characteristics | Total patients (n = 30) | Informative patients (n = 22) |
Age: yr | 36-78 (Median: 58) | 39-78 (Median: 59) |
Gender: male/female | 22 (73.3)/8 (26.7) | 16 (72.7)/6 (27.3) |
Disease etiology | ||
HBV | 18 (60.0) | 15 (68.2) |
HCV | 6 (20.0) | 3 (13.6) |
Alcohol | 6 (20.0) | 4 (18.2) |
Tumor Grade | ||
Well differentiation | 9 (30.0) | 6 (27.3) |
Moderate differentiation | 11 (36.7) | 8 (36.4) |
Poor differentiation | 10 (33.3) | 8 (36.4) |
Liver Histology | ||
Chronic hepatitis | 3 (10.0) | 2 (9.1) |
Cirrhosis | 21 (70.0) | 16 (72.7) |
Nonspecific reaction | 6 (20.0) | 4 (18.2) |
Tumor size (cm) | ||
< 2 | 4 (13.3) | 2 (9.1) |
2-5 | 14 (46.7) | 11 (50.0) |
> 5 | 12 (40.0) | 9 (40.9) |
No. of Tumor | ||
Single | 18 (60.0) | 12 (54.5) |
Multiple | 12 (40.0) | 10 (45.5) |
AJCC Stage | ||
II | 18 (60.0) | 12 (54.5) |
IIIA | 12 (40.0) | 10 (45.5) |
- Citation: Jang HS, Kang KM, Choi BO, Chai GY, Hong SC, Ha WS, Jirtle RL. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World J Gastroenterol 2008; 14(9): 1394-1398
- URL: https://www.wjgnet.com/1007-9327/full/v14/i9/1394.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1394